CHALMERS DEREK T 4
4 · Cara Therapeutics, Inc. · Filed Feb 25, 2021
Insider Transaction Report
Form 4
CHALMERS DEREK T
DirectorPresident & CEO
Transactions
- Award
Common Stock
2021-02-23+18,750→ 955,343 total - Sale
Common Stock
2021-02-25$19.33/sh−11,729$226,722→ 943,614 total
Footnotes (2)
- [F1]Represents the number of shares that vested under a performance-based restricted stock unit award (the "RSU") based on the Issuer's satisfaction of certain performance criteria of the award. In light of the performance-based vesting conditions of the award, such shares were not reportable under Section 16 until vesting was determined, which occurred on February 23, 2021. The vested shares represents the last possible vesting event of the total number of shares subject to the award.
- [F2]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person.